FDA Allows Marketing of First WSI System for Digital Pathology

News   Apr 18, 2017 | Original story from FDA

 
FDA Allows Marketing of First WSI System for Digital Pathology
 
 
 

RELATED ARTICLES

Quest Diagnostics to Acquire Cleveland HeartLab

News

Cleveland HeartLab to be the base for Quest's first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease.

READ MORE

Atrazine Alters the Sex Ratio in Blanchard's Cricket Frogs

News

Exposure of Blanchard's cricket frogs to atrazine, the second most commonly used herbicide in the United States, results in 55% fewer males than females.

READ MORE

QIAGEN and CENTOGENE to Collaborate in Bioinformatics for Genetic Diseases

News

Aiding the analysis of hereditary disorders by integrating genomic and clinical databases.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE